128 related articles for article (PubMed ID: 38309268)
1. Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8
Hu C; Qiao W; Li X; Ning ZK; Liu J; Dalangood S; Li H; Yu X; Zong Z; Wen Z; Gui J
Cell Metab; 2024 Mar; 36(3):630-647.e8. PubMed ID: 38309268
[TBL] [Abstract][Full Text] [Related]
2. Myeloid-derived suppressor cells deficient in cholesterol biosynthesis promote tumor immune evasion.
Chen Y; Xu Y; Zhao H; Zhou Y; Zhang J; Lei J; Wu L; Zhou M; Wang J; Yang S; Zhang X; Yan G; Li Y
Cancer Lett; 2023 Jun; 564():216208. PubMed ID: 37150500
[TBL] [Abstract][Full Text] [Related]
3. Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8
Li A; Chang Y; Song NJ; Wu X; Chung D; Riesenberg BP; Velegraki M; Giuliani GD; Das K; Okimoto T; Kwon H; Chakravarthy KB; Bolyard C; Wang Y; He K; Gatti-Mays M; Das J; Yang Y; Gewirth DT; Ma Q; Carbone D; Li Z
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36096533
[TBL] [Abstract][Full Text] [Related]
4. Tumor-secreted IFI35 promotes proliferation and cytotoxic activity of CD8
Li P; Zhou D; Chen D; Cheng Y; Chen Y; Lin Z; Zhang X; Huang Z; Cai J; Huang W; Lin Y; Ke H; Long J; Zou Y; Ye S; Lan P
J Biomed Sci; 2023 Jun; 30(1):47. PubMed ID: 37380972
[TBL] [Abstract][Full Text] [Related]
5. IL-36β Promotes CD8
Zhao X; Chen X; Shen X; Tang P; Chen C; Zhu Q; Li M; Xia R; Yang X; Feng C; Zhu X; Zhu Y; Sun Z; Zhang X; Lu B; Wang X
Front Immunol; 2019; 10():1803. PubMed ID: 31447838
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol Induces CD8
Ma X; Bi E; Lu Y; Su P; Huang C; Liu L; Wang Q; Yang M; Kalady MF; Qian J; Zhang A; Gupte AA; Hamilton DJ; Zheng C; Yi Q
Cell Metab; 2019 Jul; 30(1):143-156.e5. PubMed ID: 31031094
[TBL] [Abstract][Full Text] [Related]
7. Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade.
Bai X; Zhou Y; Yokota Y; Matsumoto Y; Zhai B; Maarouf N; Hayashi H; Carlson R; Zhang S; Sousa A; Sun B; Ghanbari H; Dong X; Wands JR
J Exp Clin Cancer Res; 2022 Apr; 41(1):132. PubMed ID: 35392977
[TBL] [Abstract][Full Text] [Related]
8. COPS6 promotes tumor progression and reduces CD8
Du WQ; Zhu ZM; Jiang X; Kang MJ; Pei DS
Acta Pharmacol Sin; 2023 Sep; 44(9):1890-1905. PubMed ID: 37095198
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice.
Gong Q; Hu Z; Zhang F; Cui A; Chen X; Jiang H; Gao J; Chen X; Han Y; Liang Q; Ye D; Shi L; Chin YE; Wang Y; Xiao H; Guo F; Liu Y; Zang M; Xu A; Li Y
Hepatology; 2016 Aug; 64(2):425-38. PubMed ID: 26926384
[TBL] [Abstract][Full Text] [Related]
10. Amino acids and RagD potentiate mTORC1 activation in CD8
Zhang Y; Hu H; Liu W; Yan SM; Li Y; Tan L; Chen Y; Liu J; Peng Z; Yuan Y; Huang W; Yu F; He X; Li B; Zhang H
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33883257
[TBL] [Abstract][Full Text] [Related]
11. Aldehyde dehydrogenase 2-mediated aldehyde metabolism promotes tumor immune evasion by regulating the NOD/VISTA axis.
Chen Y; Sun J; Liu J; Wei Y; Wang X; Fang H; Du H; Huang J; Li Q; Ren G; Wang X; Li H
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38088186
[TBL] [Abstract][Full Text] [Related]
12. The immune checkpoint TIGIT/CD155 promotes the exhaustion of CD8 + T cells in TNBC through glucose metabolic reprogramming mediated by PI3K/AKT/mTOR signaling.
Huang M; Yu X; Wang Q; Jiang Z; Li X; Chen W; Song C
Cell Commun Signal; 2024 Jan; 22(1):35. PubMed ID: 38216949
[TBL] [Abstract][Full Text] [Related]
13. CD8
Giles JR; Globig AM; Kaech SM; Wherry EJ
Immunity; 2023 Oct; 56(10):2231-2253. PubMed ID: 37820583
[TBL] [Abstract][Full Text] [Related]
14. Targeting inhibition of prognosis-related lipid metabolism genes including CYP19A1 enhances immunotherapeutic response in colon cancer.
Liu L; Mo M; Chen X; Chao D; Zhang Y; Chen X; Wang Y; Zhang N; He N; Yuan X; Chen H; Yang J
J Exp Clin Cancer Res; 2023 Apr; 42(1):85. PubMed ID: 37055842
[TBL] [Abstract][Full Text] [Related]
15. MK2 drives progression of pancreas and colon cancers by suppressing CD8
Jacenik D; Lebish EJ; Beswick EJ
Front Immunol; 2023; 14():1212100. PubMed ID: 37415974
[TBL] [Abstract][Full Text] [Related]
16. Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8
Hu C; Qiao W; Li X; Ning ZK; Liu J; Dalangood S; Li H; Yu X; Zong Z; Wen Z; Gui J
Cell Metab; 2024 May; 36(5):1168. PubMed ID: 38537635
[No Abstract] [Full Text] [Related]
17. mTORC1 Is a Major Regulatory Node in the FGF21 Signaling Network in Adipocytes.
Minard AY; Tan SX; Yang P; Fazakerley DJ; Domanova W; Parker BL; Humphrey SJ; Jothi R; Stöckli J; James DE
Cell Rep; 2016 Sep; 17(1):29-36. PubMed ID: 27681418
[TBL] [Abstract][Full Text] [Related]
18. TP53/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma.
Yu J; Ling S; Hong J; Zhang L; Zhou W; Yin L; Xu S; Que Q; Wu Y; Zhan Q; Bao J; Xu N; Liu Y; Chen K; Wei X; Liu Z; Feng T; Zhou L; Xie H; Wang S; Liu J; Zheng S; Xu X
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38030304
[TBL] [Abstract][Full Text] [Related]
19. Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21.
Cornu M; Oppliger W; Albert V; Robitaille AM; Trapani F; Quagliata L; Fuhrer T; Sauer U; Terracciano L; Hall MN
Proc Natl Acad Sci U S A; 2014 Aug; 111(32):11592-9. PubMed ID: 25082895
[TBL] [Abstract][Full Text] [Related]
20. Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8
Mastelic-Gavillet B; Navarro Rodrigo B; Décombaz L; Wang H; Ercolano G; Ahmed R; Lozano LE; Ianaro A; Derré L; Valerio M; Tawadros T; Jichlinski P; Nguyen-Ngoc T; Speiser DE; Verdeil G; Gestermann N; Dormond O; Kandalaft L; Coukos G; Jandus C; Ménétrier-Caux C; Caux C; Ho PC; Romero P; Harari A; Vigano S
J Immunother Cancer; 2019 Oct; 7(1):257. PubMed ID: 31601268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
